Top

Published in:

01-06-2017 | Original Article

Sitagliptin down-regulates retinol-binding protein 4 and reduces insulin resistance in gestational diabetes mellitus: a randomized and double-blind trial

Authors: Xia Sun, Zhendong Zhang, Hui Ning, Hong Sun, Xianghong Ji

Published in: Metabolic Brain Disease | Issue 3/2017

Abstract

Gestational diabetes mellitus (GDM) is a condition that affects increasing number of pregnant women worldwide. Sitagliptin was reported to alleviate symptoms of type 2 diabetes mellitus by reducing serum levels of retinol-binding protein 4 (RBP-4). We investigated the effectiveness of sitagliptin on insulin sensitivity parameters in GDM patients. Pregnant GDM women in the 2nd trimester were recruited for this study. Participants were then assigned randomly to sitagliptin treatment group or placebo treatment group, and administered sitagliptin or placebo daily for 16 weeks. Glucose and insulin profiles, as well as serum RBP-4 level, were measured at both baseline and end of the study. After 16 weeks of treatment, participants in the STL group exhibited significantly improved levels of fasting plasma glucose and serum insulin, homeostasis model of assessment of β cell function (HOMA-β) and insulin resistance (HOMA-IR), compared with those in the placebo group. Serum levels of RBP-4 were also markedly decreased in the sitagliptin treatment group, and more importantly it was positively correlated with improved insulin resistance parameters. Our study supports a potentially promising role of sitagliptin in improving insulin resistance by decreasing RBP-4 in GDM-affected women.

American Diabetes A (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl 1):S81–S90. doi:10.2337/dc14-S081 CrossRef

Casey BM, Duryea EL, Abbassi-Ghanavati M, Tudela CM, Shivvers SA, McIntire DD, Leveno KJ (2015) Glyburide in women with mild gestational diabetes: a randomized controlled trial. Obstet Gynecol 126:303–309. doi:10.1097/AOG.0000000000000967 CrossRefPubMed

Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J (2003) Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 133:1674S–1683SPubMed

Chan TF et al (2007) Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus. Reprod Sci 14:169–174. doi:10.1177/1933719106298407 CrossRefPubMed

Choi SH et al (2008) High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 93:3142–3148. doi:10.1210/jc.2007-1755 CrossRefPubMed

Derosa G, Carbone A, D'Angelo A, Querci F, Fogari E, Cicero AF, Maffioli P (2012) A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and beta-cell function. Expert Opin Pharmacother 13:2433–2442. doi:10.1517/14656566.2012.730519 CrossRefPubMed

Du M, Wang B, Liang Z, Dong M, Chen D (2015) The relationship between retinol-binding protein 4 concentrations and gestational diabetes mellitus in Chinese women. Gynecol Obstet Investig. doi:10.1159/000398794

Gardosi J, Francis A (2009) A customized standard to assess fetal growth in a US population. Am J Obstet Gynecol 201(25):e21–e27. doi:10.1016/j.ajog.2009.04.035

Hadden DR, McLaughlin C (2009) Normal and abnormal maternal metabolism during pregnancy. Semin Fetal Neonatal Med 14:66–71. doi:10.1016/j.siny.2008.09.004 CrossRefPubMed

Hamza N, Berke B, Cheze C, Agli AN, Robinson P, Gin H, Moore N (2010) Prevention of type 2 diabetes induced by high fat diet in the C57BL/6 J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J Ethnopharmacol 128:513–518. doi:10.1016/j.jep.2010.01.004 CrossRefPubMed

Hu H et al (2015) Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model. Int J Clin Exp Med 8:17902–17911PubMedPubMedCentral

Huang QT, Huang Q, Luo W, Li F, Hang LL, Yu YH, Zhong M (2015) Circulating retinol-binding protein 4 levels in gestational diabetes mellitus: a meta-analysis of observational studies. Gynecol Endocrinol 31:337–344. doi:10.3109/09513590.2015.1005594 CrossRefPubMed

Kayal A et al (2016) Women in India with gestational diabetes mellitus strategy (WINGS): methodology and development of model of care for gestational diabetes mellitus (WINGS 4). Indian J Endocrinol Metab 20:707–715. doi:10.4103/2230-8210.189230 CrossRefPubMedPubMedCentral

Khovidhunkit W, Pruksakorn P, Plengpanich W, Tharavanij T (2012) Retinol-binding protein 4 is not associated with insulin resistance in pregnancy. Metabolism 61:65–69. doi:10.1016/j.metabol.2011.05.019 CrossRefPubMed

Klein K et al (2010) Retinol-binding protein 4 in patients with gestational diabetes mellitus. J Women's Health (Larchmt) 19:517–521. doi:10.1089/jwh.2009.1615 CrossRef

Kondo Y et al (2016) Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial. Diabetol Metab Syndr 8:15. doi:10.1186/s13098-016-0131-y CrossRefPubMedPubMedCentral

Lain KY, Catalano PM (2007) Metabolic changes in pregnancy. Clin Obstet Gynecol 50:938–948. doi:10.1097/GRF.0b013e31815a5494 CrossRefPubMed

Lamers D et al (2011) Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60:1917–1925. doi:10.2337/db10-1707 CrossRefPubMedPubMedCentral

Legardeur H, Girard G, Journy N, Ressencourt V, Durand-Zaleski I, Mandelbrot L (2014) Factors predictive of macrosomia in pregnancies with a positive oral glucose challenge test: importance of fasting plasma glucose. Diabetes Metab 40:43–48. doi:10.1016/j.diabet.2013.01.008 CrossRefPubMed

Lewandowski KC et al (2008) Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1). Gynecol Endocrinol 24:300–305. doi:10.1080/09513590802141052 CrossRefPubMed

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed

Muscelli E et al (2012) Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. J Clin Endocrinol Metab 97:2818–2826. doi:10.1210/jc.2012-1205 CrossRefPubMed

Noy N (2000) Retinoid-binding proteins: mediators of retinoid action. Biochem J 348(Pt 3):481–495CrossRefPubMedPubMedCentral

Rohrborn D, Bruckner J, Sell H, Eckel J (2016) Reduced DPP4 activity improves insulin signaling in primary human adipocytes. Biochem Biophys Res Commun 471:348–354. doi:10.1016/j.bbrc.2016.02.019 CrossRefPubMed

Saucedo R, Zarate A, Basurto L, Hernandez M, Puello E, Mendoza-Lorenzo P, Ostrosky-Wegman P (2014) RBP4 gene variants are associated with insulin resistance in women with previous gestational diabetes. Dis Markers 2014:269208. doi:10.1155/2014/269208 CrossRefPubMedPubMedCentral

Sell H et al (2013) Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro. Diabetes Care 36:4083–4090. doi:10.2337/dc13-0496 CrossRefPubMedPubMedCentral

Suresh PS, Nuggehally SR, Mullangi R (2016) A concise review of the bioanalytical methods for the quantitation of sitagliptin, an important dipeptidyl peptidase-4 (DPP4) inhibitor, utilized for the pharmacokinetic characterization of the drug. Biomed Chromatogr. doi:10.1002/bmc.3705

Wiwanitkit V (2012) Retinol-binding protein 4, insulin resistance and pregnancy. Metabolism 61:e9. doi:10.1016/j.metabol.2012.03.008 CrossRefPubMed

Zhaoxia L, Mengkai D, Qin F, Danqing C (2014) Significance of RBP4 in patients with gestational diabetes mellitus: a case-control study of Han Chinese women. Gynecol Endocrinol 30:161–164. doi:10.3109/09513590.2013.871515 CrossRefPubMed

Title: Sitagliptin down-regulates retinol-binding protein 4 and reduces insulin resistance in gestational diabetes mellitus: a randomized and double-blind trial
Authors: Xia Sun
Zhendong Zhang
Hui Ning
Hong Sun
Xianghong Ji
Publication date: 01-06-2017
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 3/2017
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-017-9958-7

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Sitagliptin down-regulates retinol-binding protein 4 and reduces insulin resistance in gestational diabetes mellitus: a randomized and double-blind trial

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2017

Cognitive impairment is correlated with insulin resistance degree: the “PA-NICO-study”

Serum trace elements are associated with hemostasis, lipid spectrum and inflammatory markers in men suffering from acute ischemic stroke

Investigation of thymol effect on learning and memory impairment induced by intrahippocampal injection of amyloid beta peptide in high fat diet- fed rats

The oral administration of D-galactose induces abnormalities within the mitochondrial respiratory chain in the brain of rats

Ghrelin ameliorates nerve growth factor Dysmetabolism and inflammation in STZ-induced diabetic rats

Effects of obesity on protein kinase C, brain creatine kinase, transcription, and autophagy in cochlea